White Papers

Addressing Total Cost of Care Across the Specialty Population 204 115 Shields Health Solutions

Addressing Total Cost of Care Across the Specialty Population

This white paper describes the impact of health system specialty pharmacy utilizing an integrated care model on clinical outcomes and total cost of care.  

How Specialty Pharmacy Can Drive Better Outcomes in Diabetes 204 115 Shields Health Solutions

How Specialty Pharmacy Can Drive Better Outcomes in Diabetes

This white paper explores the benefits of applying a high-touch specialty pharmacy care model, such as the Shields Diabetes Care Program, in reducing HbA1c levels and providing other clinical and…

How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis 204 115 Shields Health Solutions

How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis

This white paper explores how a high-touch integrated specialty pharmacy care model can help patients with cystic fibrosis manage the complexity of their treatment regimen and achieve their therapy goals.…

How Specialty Pharmacy Can Drive Better Outcomes in Multiple Sclerosis 204 115 Shields Health Solutions

How Specialty Pharmacy Can Drive Better Outcomes in Multiple Sclerosis

This white paper explores how a high-touch IDN (Integrated Delivery Network) specialty pharmacy model can help MS patients overcome barriers to medication access and achievement of therapy goals, including limited…

More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patients 204 115 Shields Health Solutions

More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patients
Drug manufacturers, payers and high-performing health system specialty pharmacies can leverage the size, scope and scale of a partner like Excelera to create efficiencies and improve the care of complex patients. Among the topics in this white paper:
Continuing Trends, Unexpected Changes: Optimizing Specialty Pharmacy in a New Environment 204 115 Shields Health Solutions

Continuing Trends, Unexpected Changes: Optimizing Specialty Pharmacy in a New Environment

This white paper describes the growth of health system specialty pharmacy in recent years, acknowledges the disruption caused by COVID-19, and discusses opportunities to optimize specialty pharmacy with data-driven solutions,…

How Health System Specialty Pharmacies Will Help Payers Succeed in a Value-Based, Data-Driven Future 204 115 Shields Health Solutions

How Health System Specialty Pharmacies Will Help Payers Succeed in a Value-Based, Data-Driven Future

This white paper highlights the importance of collaboration between payers and health systems and the benefits of carving in specialty pharmacy access at the point of care. These partnerships are…

Health Systems Working Together Strengthen Their In-House Specialty Pharmacy Capabilities and Optimize Patient Care 204 115 Shields Health Solutions

Health Systems Working Together Strengthen Their In-House Specialty Pharmacy Capabilities and Optimize Patient Care

This white paper provides background on the specialty pharmacy market, describes the role of health systems in specialty pharmacy care, acknowledges the challenges they face, and outlines the benefits of…

How Health Systems Can Optimize Revenue Streams and Improve the Patient Experience by Providing Home Infusion Pharmacy Services 204 115 Shields Health Solutions

How Health Systems Can Optimize Revenue Streams and Improve the Patient Experience by Providing Home Infusion Pharmacy Services
This white paper describes the home infusion opportunity, outlines factors to consider in deciding whether to launch a home infusion program, and recommends resources. A case study describing an Excelera Home Infusion Solutions engagement is included. • Home infusion is a growing category. • Many health systems find that home infusion aligns with clinical and financial goals. • A consultant can help health systems get to market faster as they develop their in-house home infusion expertise.
  • 1
  • 2